Related Experiment Video
Updated: Jun 1, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Dutch guideline for the management of hypertensive crisis -- 2010 revision
B J H van den Born1, J J Beutler, C A J M Gaillard
1Department of Internal & Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands. b.j.vandenborn@amc.uva.nl
Insights
Hypertensive crises, including urgencies and emergencies, require updated management strategies. The 2010 Dutch guideline refines terminology and treatment for better patient outcomes in acute hypertensive disorders.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Hypertensive crises, encompassing urgencies and emergencies, are common acute hypertensive disorders.
- Despite advances in hypertension treatment, complications and the need for renal replacement therapy persist.
- The Netherlands introduced a guideline in 2003 for standardized, evidence-based hypertensive crisis management.
Purpose of the Study:
- To provide an overview of current hypertensive crisis management.
- To discuss significant changes in the 2010 revised Dutch guideline.
- To update terminology and treatment recommendations for hypertensive emergencies and urgencies.
Main Methods:
- Review of current management practices for hypertensive crisis.
- Analysis of changes incorporated in the 2010 guideline revision.
- Comparison of treatment options for hypertensive emergencies and urgencies.
Main Results:
- Terminology updated: 'malignant hypertension' replaced by 'hypertensive crisis with retinopathy'.
- Hypertensive crisis with retinopathy reclassified as an emergency.
- Treatment shifts favor nicardipine for perioperative hypertension and labetalol for pre-eclampsia; oral nifedipine retard recommended for urgencies.
Conclusions:
- The 2010 guideline refines hypertensive crisis classification and treatment, emphasizing specific drug choices for emergencies and urgencies.
- New sections address management based on target organ involvement.
- Public awareness and treatment of hypertension are crucial for reducing incidence and complications.
Abstract:
Hypertensive crises are divided into hypertensive urgencies and emergencies. Together they form a heterogeneous group of acute hypertensive disorders depending on the presence or type of target organs involved. Despite better treatment options for hypertension, hypertensive crisis and its associated complications remain relatively common. In the Netherlands the number of patients starting renal replacement therapy because of 'malignant hypertension' has increased in the past two decades. In 2003, the first Dutch guideline on hypertensive crisis was released to allow a standardised evidence-based approach for patients presenting with a hypertensive crisis. In this paper we give an overview of the current management of hypertensive crisis and discuss several important changes incorporated in the 2010 revision. These changes include a modification in terminology replacing 'malignant hypertension' with 'hypertensive crisis with retinopathy and reclassification of hypertensive crisis with retinopathy under hypertensive emergencies instead of urgencies. With regard to the treatment of hypertensive emergencies, nicardipine instead of nitroprusside or labetalol is favoured for the management of perioperative hypertension, whereas labetalol has become the drug of choice for the treatment of hypertension associated with pre-eclampsia. For the treatment of hypertensive urgencies, oral administration of nifedipine retard instead of captopril is recommended as first-line therapy. In addition, a section on the management of hypertensive emergencies according to the type of target organ involved has been added. Efforts to increase the awareness and treatment of hypertension in the population at large may lower the incidence of hypertensive crisis and its complications.
Related Concept Videos
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Heart Failure V: Medical Management